Additional file 2: of Nilotinib (Tasignaâ˘) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

Gordon, Jessica; Martyanov, Viktor; Magro, Cynthia; Wildman, Horatio; Wood, Tammara; Huang, Wei-Ti; Crow, Mary; Whitfield, Michael; Spiera, Robert

doi:10.6084/m9.figshare.c.3636080_D5.v1

13075_2015_721_MOESM2_ESM.docx (15.18 kB)

Additional file 2: of Nilotinib (Tasignaâ˘) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

journal contribution

posted on 2015-08-18, 05:00 authored by Jessica Gordon, Viktor Martyanov, Cynthia Magro, Horatio Wildman, Tammara Wood, Wei-Ti Huang, Mary Crow, Michael Whitfield, Robert Spiera

Dermatopathology results. ÎąSMA alpha smooth muscle actin, Egr early growth response protein. (DOCX 15 kb)

History

Usage metrics

Keywords

muscle actin Additional trial Dermatopathology results growth response protein Nilotinib open-label DOCX 15 kb Egr Îą SMA Tasigna sclerosis

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC